The Oncosearch | Oncotarget

Retraction: microRNA526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma Retraction

Xin Liu, Liu Yang, Jianfeng Tu, Wenwei Cai, Meiqi Zhang, Zhangxuan Shou, Yingmin Yao, Qiuran Xu

Published Apr 24, 2026 · Vol. 17, No. 1 · pp. 195-196

Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma Retraction

Xin Zheng, Tao Song, Changwei Dou, Yuli Jia, Qingguang Liu

Published Apr 24, 2026 · Vol. 17, No. 1 · pp. 192-192

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience Research Paper

Fei Fei, Milhan Telatar, Vanina Tomasian, Lisa Chang, Olga Danilova, Javier Arias-Stella, Raju Pillai, Lorinda Soma, Parastou Tizro, Pamela S. Becker, Anthony S. Stein, Guido Marcucci, Michelle Afkhami

Published Jun 7, 2025 · Vol. 16, No. 1 · pp. 495-507

Keywords: Blastic plasmacytoid dendritic cell neoplasm (BPDCN), Next-generation sequencing (NGS), CCDC50

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies Research Paper

Nina Klimova, Sandra Close, David M. Kurtz, Richard D. Hockett, Laura Hyland

Published May 2, 2025 · Vol. 16, No. 1 · pp. 329-336

Keywords: MRD, ctDNA, PhasED-Seq, CLARITY, residual disease

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Whitney L. Hensing, Emily L. Podany, James J. Sears, Shaili Tapiavala, Andrew A. Davis

Published Jan 9, 2025 · Vol. 16, No. 1 · pp. 11-27

Keywords: breast cancer, HER2-low, genomics

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma Research Paper

Caroline Naomi Valdez, Gabriela Athziri Sánchez-Zuno, Lais Osmani, Wael Ibrahim, Anjela Galan, Antonietta Bacchiocchi, Ruth Halaban, Rajan P. Kulkarni, Insoo Kang, Richard Bucala, Thuy Tran

Published Jul 15, 2024 · Vol. 15, No. 1 · pp. 507-520

Keywords: MIF, DDT, melanoma, immune checkpoint inhibition, cancer transcriptomics

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity Editorial

Marcus Schmidt, Hans-Anton Lehr, Katrin Almstedt

Published Jun 15, 2024 · Vol. 15, No. 1 · pp. 418-420

Keywords: breast cancer, HER2, HER2-low, prognostic, predictive

Correction: Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer Correction

Zhilan Chen, Yingyan Han, Chengwen Song, Huafang Wei, Ying Chen, Kecheng Huang, Shuang Li, Ding Ma, Shixuan Wang, Jing Wang, Qiping Lu

Published Oct 24, 2023

Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity Research Paper

Gulnur Zhunussova, Nazgul Omarbayeva, Dilyara Kaidarova, Saltanat Abdikerim, Natalya Mit, Ilya Kisselev, Kanagat Yergali, Aigul Zhunussova, Tatyana Goncharova, Aliya Abdrakhmanova, Leyla Djansugurova

Published Sep 25, 2023 · Vol. 14, No. 1 · pp. 860-877

Keywords: early-onset breast cancer, triple negative breast cancer, next-generation sequencing, pathogenic variant, Kazakh population

Addendum: Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Addendum

Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima

Published Sep 7, 2023

Addendum: Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model Addendum

Gerrit Spanier, Daniela Weidt, Dirk Hellwig, Johannes K.H. Meier, Torsten E. Reichert, Jirka Grosse

Published Aug 29, 2023

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

Meghali Goswami, Jeffrey Schlom, Renee N. Donahue

Published Aug 3, 2023 · Vol. 14, No. 1 · pp. 758-774

Keywords: HPV-associated malignancies, immunotherapy, circulating tumor DNA, circulating tumor cells, HPV-specific antibodies

Addendum: What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Addendum

Christian Mark Farag, Ryan Antar, Sinan Akosman, Matthew Ng, Michael J. Whalen

Published Jul 27, 2023 · Vol. 14, No. 1 · pp. 748-748

Retraction: The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma Retraction

Yi Xu, Kaiming Leng, Zhenglong Li, Fumin Zhang, Xiangyu Zhong, Pengcheng Kang, Xingming Jiang, Yunfu Cui

Published Apr 27, 2023 · Vol. 14, No. 1 · pp. 779-779

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Research Paper

Ellery Altshuler, Raymond Richhart, William King, Mahmoud Aryan, Akash Mathavan, Akshay Mathavan, Keegan Hones, Daniel F. Leach III, Logan Pucci, Joshua Riklan, Pat Haley, Ilyas Sahin, Brian Ramnaraign, Sherise Rogers, Ibrahim Nassour, Steven Hughes, Thomas J. George, Jesus Fabregas

Published Apr 4, 2023 · Vol. 14, No. 1 · pp. 351-357

Keywords: duodenal adenocarcinoma, carbohydrate antigen, CA 19-9, carcinoembrionic antigen, CEA

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior Research Paper

Fang Cheng, Victor Chérouvrier Hansson, Grigorios Georgolopoulos, Katrin Mani

Published Mar 13, 2023 · Vol. 14, No. 1 · pp. 219-235

Keywords: Glypican-1, TCGA, bladder carcinoma, hepatocellular carcinoma, glioma

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

Christian Mark Farag, Ryan Antar, Sinan Akosman, Matthew Ng, Michael J. Whalen

Published Feb 15, 2023 · Vol. 14, No. 1 · pp. 153-172

Keywords: HALP score, biomarker, prognosis, cancer, survival

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Research Perspective

Shakthivel Mani, Abhishek Chatterjee, Archya Dasgupta, Neelam Shirsat, Sridhar Epari, Girish Chinnaswamy, Tejpal Gupta

Published Feb 2, 2023 · Vol. 14, No. 1 · pp. 105-110

Keywords: de-intensification, medulloblastoma, molecular, survival, toxicity

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Noriyuki Hirahara, Takeshi Matsubara, Shunsuke Kaji, Hikota Hayashi, Yohei Sasaki, Koki Kawakami, Ryoji Hyakudomi, Tetsu Yamamoto, Yoshitsugu Tajima

Published Jan 25, 2023 · Vol. 14, No. 1 · pp. 71-82

Keywords: gastric cancer, laparoscopic gastrectomy, novel predictive index, inflammation-combined prognostic index, cancer-specific survival

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Jun Gong, Michelle Guan, Haesoo Kim, Natalie Moshayedi, Sejal Mehta, Galen Cook-Wiens, Brent K. Larson, Jenny Zhou, Rishi Patel, Isaac Lapite, Veronica R. Placencio-Hickok, Richard Tuli, Ronald B. Natale, Andrew E. Hendifar

Published Oct 25, 2022 · Vol. 13, No. 1 · pp. 1202-1214

Keywords: hyaluronan, hyaluronic acid, biomarker, prognostic, predictive

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Retraction: microRNA526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma Retraction

Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma Retraction

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience Research Paper

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies Research Paper

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma Research Paper

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity Editorial

Correction: Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer Correction

Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity Research Paper

Addendum: Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Addendum

Addendum: Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model Addendum

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

Addendum: What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Addendum

Retraction: The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma Retraction

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Research Paper

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior Research Paper

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Retraction: microRNA526b servers as a prognostic factor and exhibits tumor suppressive property by targeting Sirtuin 7 in hepatocellular carcinoma Retraction

Retraction: CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelialmesenchymal transition in hepatocellular carcinoma Retraction

Genetic characteristics of blastic plasmacytoid dendritic cell neoplasm: A single institution experience Research Paper

Analytical validation of a circulating tumor DNA assay using PhasED-Seq technology for detecting residual disease in B-cell malignancies Research Paper

Evolving concepts in HER2-low breast cancer: Genomic insights, definitions, and treatment paradigms Review

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma Research Paper

HER2-low and HER2-zero in breast cancer between prognosis, prediction and entity Editorial

Correction: Systematic review and meta-analysis of the prognostic significance of microRNAs in cervical cancer Correction

Determination of genetic predisposition to early breast cancer in women of Kazakh ethnicity Research Paper

Addendum: Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Addendum

Addendum: Total lesion glycolysis in oral squamous cell carcinoma as a biomarker derived from pre-operative FDG PET/CT outperforms established prognostic factors in a newly developed multivariate prediction model Addendum

Peripheral surrogates of tumor burden to guide chemotherapeutic and immunotherapeutic strategies for HPV-associated malignancies Review

Addendum: What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Addendum

Retraction: The prognostic potential and carcinogenesis of long non-coding RNA TUG1 in human cholangiocarcinoma Retraction

Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study Research Paper

Attenuation of cancer proliferation by suppression of glypican-1 and its pleiotropic effects in neoplastic behavior Research Paper

What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types Review

WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Research Perspective

Novel inflammation-combined prognostic index to predict survival outcomes in patients with gastric cancer Research Paper

Tumor hyaluronan as a novel biomarker in non-small cell lung cancer: A retrospective study Research Paper